Yongchang Zheng
Overview
Explore the profile of Yongchang Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
678
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Deng K, Xing J, Xu G, Ma R, Jin B, Leng Z, et al.
World J Surg Oncol
. 2024 Oct;
22(1):263.
PMID: 39354502
Background: Gallbladder cancer (GBC) is a highly aggressive malignancy, with limited survival profiles after curative surgeries. This study aimed to develop a practical model for predicting the postoperative overall survival...
2.
Deng K, Chen T, Leng Z, Yang F, Lu T, Cao J, et al.
Radiol Med
. 2024 Jul;
129(8):1099-1117.
PMID: 39060885
Introduction: Transarterial chemoembolization (TACE) is one of the predominant locoregional therapeutic modalities for addressing hepatocellular carcinoma (HCC). However, achieving precise prognostic predictions and effective patient selection remains a challenging pursuit....
3.
Zhang J, Zhang L, Yang X, Zheng Y, Xu H, Du S, et al.
Sci Rep
. 2024 Jul;
14(1):15827.
PMID: 38982109
The influence of liver fibrosis on the rate of liver regeneration and complications following ALPPS has yet to be fully understood. This study aimed to scrutinize the effects of liver...
4.
Jiang Z, Wu Y, Miao Y, Deng K, Yang F, Xu S, et al.
Genomics Proteomics Bioinformatics
. 2024 Jun;
22(1).
PMID: 38886186
Large-scale transcriptomic data are crucial for understanding the molecular features of hepatocellular carcinoma (HCC). Integrated 15 transcriptomic datasets of HCC clinical samples, the first version of HCC database (HCCDB v1.0)...
5.
Wu X, Chen X, Liu X, Jin B, Zhang Y, Wang Y, et al.
Heliyon
. 2024 Jun;
10(10):e30841.
PMID: 38826728
Background: Long noncoding RNAs (lncRNAs) have emerged as critical regulators of colorectal cancer (CRC) progression, but their roles and underlying mechanisms in colorectal cancer liver metastases (CRLMs) remain poorly understood....
6.
Deng K, Xie Y, Shao J, Lai Z, Zheng Y, Liu B
J Endovasc Ther
. 2024 Jun;
:15266028241256521.
PMID: 38826025
This article showed images of a patient with idiopathic serial right internal mammary artery true aneurysms treated by endovascular embolization, which is a rare diagnosis and should be considered in...
7.
R-MFE-TCN: A correlation prediction model between body surface and tumor during respiratory movement
Wang X, Yang C, Liu Z, Zhang J, Xue C, Xing L, et al.
Med Phys
. 2024 May;
51(9):6075-6089.
PMID: 38801342
Background: 2D CT image-guided radiofrequency ablation (RFA) is an exciting minimally invasive treatment that can destroy liver tumors without removing them. However, CT images can only provide limited static information,...
8.
Deng K, Xing J, Xu G, Jin B, Wan X, Zheng Y, et al.
Cancer Cell Int
. 2023 Oct;
23(1):239.
PMID: 37833757
Hepatocellular carcinoma (HCC) is the most predominant primary liver cancer, causing many illnesses and deaths worldwide. The insidious clinical presentation, difficulty in early diagnosis, and the highly malignant nature make...
9.
Deng K, Yang F, Liu X, Deng M, Leng Z, Zheng Y
Clin Res Hepatol Gastroenterol
. 2023 Sep;
47(8):102211.
PMID: 37734443
No abstract available.
10.
Yang F, Liu G, Wei J, Dong Y, Zhang X, Zheng Y
Nutrients
. 2023 Sep;
15(17).
PMID: 37686845
Bladder cancer (BC) is the predominant neoplasm affecting the urinary system and ranks among the most widespread malignancies globally. The causes of bladder cancer include genetic factors; age; sex; and...